Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...

書誌詳細
主要な著者:	M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova
フォーマット:	論文
言語:	Russian
出版事項:	LLC "Publishing House OKI" 2024-06-01
シリーズ:	Антибиотики и Химиотерапия
主題:	influenza rheumatoid arthritis ankylosing spondylitis psoriatic arthritis vaccination efficacy immunogenicity safety
オンライン･アクセス:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1129

類似資料

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
著者:: M. M. Baranova, 等
出版事項: (2024-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
著者:: D. V. Bukhanova, 等
出版事項: (2018-07-01)

Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
著者:: Alyssa Howren, 等
出版事項: (2025-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
著者:: Matthew Carroll, 等
出版事項: (2015-01-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
著者:: Svedbom A, 等
出版事項: (2017-01-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
著者:: Zlatković-Švenda Mirjana, 等
出版事項: (2022-01-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
著者:: Hermine Leroi, 等
出版事項: (2020-05-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
著者:: I Z Gaydukova, 等
出版事項: (2018-12-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
著者:: Takacs P, 等
出版事項: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
著者:: Joshua L. Lee, 等
出版事項: (2018-08-01)

The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
著者:: M. M. Baranova, 等
出版事項: (2021-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
著者:: M. Rossini, 等
出版事項: (2015-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
著者:: Taras S. Panevin, 等
出版事項: (2024-06-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
著者:: I. Pantano, 等
出版事項: (2023-03-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
著者:: Milena Iwaszko, 等
出版事項: (2021-11-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
著者:: Viola Sacchi, 等
出版事項: (2010-06-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
著者:: Krzysztof Bonek, 等
出版事項: (2022-04-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
著者:: Santhi Mantravadi, 等
出版事項: (2020-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
著者:: Philip Brenner, 等
出版事項: (2020-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
著者:: E. E. Gubar, 等
出版事項: (2023-08-01)

Nod-like receptors in inflammatory arthritis
著者:: Sahib Singh Madahar, 等
出版事項: (2024-02-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
著者:: Xinlin Nie, 等
出版事項: (2023-10-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
著者:: M. Elaine Husni, 等
出版事項: (2022-03-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
著者:: Christian Dejaco, 等
出版事項: (2022-06-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
著者:: D. V. Bukhanova, 等
出版事項: (2018-07-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
著者:: Eleonora Alina Dragomir-Lica, 等
出版事項: (2023-09-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
著者:: Hanna Park, 等
出版事項: (2024-01-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
著者:: Acar M, 等
出版事項: (2018-11-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
著者:: Yu. V. Muravyev, 等
出版事項: (2020-05-01)

Adherence to biological therapies in patients with chronic inflammatory arthropathies
著者:: Noemí Martínez-López de Castro, 等
出版事項: (2019-07-01)

Unraveling immune cell heterogeneity in autoimmune arthritis: insights from single-cell RNA sequencing
著者:: Sotaro Nakajima, 等
出版事項: (2024-10-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
著者:: Andrea Picchianti-Diamanti, 等
出版事項: (2025-02-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
著者:: Giovanni Cioffi, 等
出版事項: (2021-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
著者:: I. Z. Gaidukova, 等
出版事項: (2015-03-01)

Prevalence of spondyloarthritis and its subtypes - are they really comparable?
著者:: Zlatković-Švenda Mirjana I., 等
出版事項: (2019-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
著者:: R. M. Balabanova, 等
出版事項: (2021-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
著者:: Muhammad Haroon, 等
出版事項: (2018-04-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
著者:: Jaroslaw Nowakowski, 等
出版事項: (2023-10-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
著者:: Tacjana Anna Barczyńska, 等
出版事項: (2015-12-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
著者:: T. V. Dubinina, 等
出版事項: (2023-02-01)